Underlying growth in revenue in 2010 by business segment reconciles to reported growth, the most directly comparable financial measure calculated in accordance with IFRS, as follows: Constant currency Reported exchange Underlying growth effect growth % % % Orthopaedics 3 1 2 Endoscopy 8 1 7 Advanced Wound Management 8 1 7 Total revenue 5 1 4 Underlying growth in revenue by business segment reconciles to reported growth in 2009as follows: Constant currency Reported exchange Underlying growth effect growth % % % Orthopaedics 1 2 1 Endoscopy 1 2 1 Advanced Wound Management - 6 6 Total revenue 1 3 2 Trading Profit Trading profit is a trend measure which presents the long-term profitability of the Group excluding the impact of specific transactions that management considers affect the Groups short-term profitability.
The Group presents this measure to assist investors in their understanding of trends.
The Group has identified the following items, where material, as those to be excluded from operating profit when arriving at trading profit: acquisition and disposal related items including amortisation of acquisition intangible assets and impairments: significant restructuring events: and gains and losses resulting fromlegal disputes and uninsured losses.
Trading profit in 2010 reconciles to operating profit, the most directly comparable financial measure calculated in accordance with IFRS, as follows: Amortisation Restructuring of acquisition and intangibles Operating rationalisation and profit costs impairments Trading profit $ million $ million $ million $ million Orthopaedics 503 8 25 536 Endoscopy 197 2 1 200 Advanced Wound Management 220 5 8 233 Total 920 15 34 969 2010Annual Report 25 InvestorInformation CompanyAccounts GroupAccounts  CorporateGovernance BusinessReview, Descriptionof theGroup Report Statement 
